BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

184 related articles for article (PubMed ID: 20930271)

  • 1. A novel progranulin mutation causing frontotemporal lobar degeneration with heterogeneous phenotypic expression.
    Rossi G; Piccoli E; Benussi L; Caso F; Redaelli V; Magnani G; Binetti G; Ghidoni R; Perani D; Giaccone G; Tagliavini F
    J Alzheimers Dis; 2011; 23(1):7-12. PubMed ID: 20930271
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A mutation in the 5'-UTR of GRN gene associated with frontotemporal lobar degeneration: phenotypic variability and possible pathogenetic mechanisms.
    Puoti G; Lerza MC; Ferretti MG; Bugiani O; Tagliavini F; Rossi G
    J Alzheimers Dis; 2014; 42(3):939-47. PubMed ID: 25024321
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A novel frameshift GRN mutation results in frontotemporal lobar degeneration with a distinct clinical phenotype in two siblings: case report and literature review.
    Hosaka T; Ishii K; Miura T; Mezaki N; Kasuga K; Ikeuchi T; Tamaoka A
    BMC Neurol; 2017 Sep; 17(1):182. PubMed ID: 28915852
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Association of the variant Cys139Arg at GRN gene to the clinical spectrum of frontotemporal lobar degeneration.
    Piaceri I; Pradella S; Cupidi C; Nannucci S; Polito C; Bagnoli S; Tedde A; Smirne N; Anfossi M; Gallo M; Bernardi L; Colao R; Maletta R; Bruni AC; Sorbi S; Nacmias B
    J Alzheimers Dis; 2014; 40(3):679-85. PubMed ID: 24503614
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Serum progranulin levels in patients with frontotemporal lobar degeneration and Alzheimer's disease: detection of GRN mutations in a Spanish cohort.
    Antonell A; Gil S; Sánchez-Valle R; Balasa M; Bosch B; Prat MC; Chiollaz AC; Fernández M; Yagüe J; Molinuevo JL; Lladó A
    J Alzheimers Dis; 2012; 31(3):581-91. PubMed ID: 22647257
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Plasma progranulin levels in cortical dementia phenotypes with asymmetric perisylvian atrophy.
    Gómez-Tortosa E; Guerrero-López R; Gil-Neciga E; Franco E; del Ser T; Jiménez Escrig A; Pérez-Pérez J; Sainz MJ
    Eur J Neurol; 2013 Sep; 20(9):1319-24. PubMed ID: 23724906
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A Novel Loss-of-Function GRN Mutation p.(Tyr229*): Clinical and Neuropathological Features.
    Kuuluvainen L; Pöyhönen M; Pasanen P; Siitonen M; Rummukainen J; Tienari PJ; Paetau A; Myllykangas L
    J Alzheimers Dis; 2017; 55(3):1167-1174. PubMed ID: 27767988
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Brain perfusion patterns in familial frontotemporal lobar degeneration.
    Seelaar H; Papma JM; Garraux G; de Koning I; Reijs AE; Valkema R; Rozemuller AJ; Salmon E; van Swieten JC
    Neurology; 2011 Jul; 77(4):384-92. PubMed ID: 21753175
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Frontotemporal Lobar Degeneration.
    Premi E; Padovani A; Borroni B
    Adv Exp Med Biol; 2012; 724():114-27. PubMed ID: 22411238
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cerebrospinal fluid biomarkers in Progranulin mutations carriers.
    Carecchio M; Fenoglio C; Cortini F; Comi C; Benussi L; Ghidoni R; Borroni B; De Riz M; Serpente M; Cantoni C; Franceschi M; Albertini V; Monaco F; Rainero I; Binetti G; Padovani A; Bresolin N; Scarpini E; Galimberti D
    J Alzheimers Dis; 2011; 27(4):781-90. PubMed ID: 21891865
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Reduced Tau protein expression is associated with frontotemporal degeneration with progranulin mutation.
    Papegaey A; Eddarkaoui S; Deramecourt V; Fernandez-Gomez FJ; Pantano P; Obriot H; Machala C; Anquetil V; Camuzat A; Brice A; Maurage CA; Le Ber I; Duyckaerts C; Buée L; Sergeant N; Buée-Scherrer V
    Acta Neuropathol Commun; 2016 Jul; 4(1):74. PubMed ID: 27435172
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A cluster of progranulin C157KfsX97 mutations in Southern Italy: clinical characterization and genetic correlations.
    Coppola C; Saracino D; Puoti G; Lus G; Dato C; Le Ber I; Pariente J; Caroppo P; Piccoli E; Tagliavini F; Di Iorio G; Rossi G
    Neurobiol Aging; 2017 Jan; 49():219.e5-219.e13. PubMed ID: 27814992
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Secretory leukocyte protease inhibitor protein regulates the penetrance of frontotemporal lobar degeneration in progranulin mutation carriers.
    Ghidoni R; Flocco R; Paterlini A; Glionna M; Caruana L; Tonoli E; Binetti G; Benussi L
    J Alzheimers Dis; 2014; 38(3):533-9. PubMed ID: 24018267
    [TBL] [Abstract][Full Text] [Related]  

  • 14. HDDD2 is a familial frontotemporal lobar degeneration with ubiquitin-positive, tau-negative inclusions caused by a missense mutation in the signal peptide of progranulin.
    Mukherjee O; Pastor P; Cairns NJ; Chakraverty S; Kauwe JS; Shears S; Behrens MI; Budde J; Hinrichs AL; Norton J; Levitch D; Taylor-Reinwald L; Gitcho M; Tu PH; Tenenholz Grinberg L; Liscic RM; Armendariz J; Morris JC; Goate AM
    Ann Neurol; 2006 Sep; 60(3):314-22. PubMed ID: 16983685
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Novel progranulin mutations with reduced serum-progranulin levels in frontotemporal lobar degeneration.
    Chiang HH; Forsell C; Lilius L; Öijerstedt L; Thordardottir S; Shanmugarajan K; Westerlund M; Nennesmo I; Thonberg H; Graff C
    Eur J Hum Genet; 2013 Nov; 21(11):1260-5. PubMed ID: 23463024
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical and Neuroimaging Aspects of Familial Frontotemporal Lobar Degeneration Associated with MAPT and GRN Mutations.
    Boeve BF; Rosen H
    Adv Exp Med Biol; 2021; 1281():77-92. PubMed ID: 33433870
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The neuroimaging signature of frontotemporal lobar degeneration associated with Granulin mutations: an effective connectivity study.
    Premi E; Grassi M; Gazzina S; Paghera B; Pepe D; Archetti S; Padovani A; Borroni B
    J Nucl Med; 2013 Jul; 54(7):1066-71. PubMed ID: 23687363
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prevalence of frontotemporal lobar degeneration in an isolated population: the Vallecamonica study.
    Gilberti N; Turla M; Alberici A; Bertasi V; Civelli P; Archetti S; Padovani A; Borroni B
    Neurol Sci; 2012 Aug; 33(4):899-904. PubMed ID: 22127750
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Distinct clinical characteristics of C9orf72 expansion carriers compared with GRN, MAPT, and nonmutation carriers in a Flanders-Belgian FTLD cohort.
    Van Langenhove T; van der Zee J; Gijselinck I; Engelborghs S; Vandenberghe R; Vandenbulcke M; De Bleecker J; Sieben A; Versijpt J; Ivanoiu A; Deryck O; Willems C; Dillen L; Philtjens S; Maes G; Bäumer V; Van Den Broeck M; Mattheijssens M; Peeters K; Martin JJ; Michotte A; Santens P; De Jonghe P; Cras P; De Deyn PP; Cruts M; Van Broeckhoven C
    JAMA Neurol; 2013 Mar; 70(3):365-73. PubMed ID: 23338682
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Missense mutation in GRN gene affecting RNA splicing and plasma progranulin level in a family affected by frontotemporal lobar degeneration.
    Luzzi S; Colleoni L; Corbetta P; Baldinelli S; Fiori C; Girelli F; Silvestrini M; Caroppo P; Giaccone G; Tagliavini F; Rossi G
    Neurobiol Aging; 2017 Jun; 54():214.e1-214.e6. PubMed ID: 28285794
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.